Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Scancell Holdings (SCLP) Share Price

Price 9.65p on 30-10-2025 at 19:40:08
Change 0.00p 0%
Buy 9.80p
Sell 9.50p
Last Trade: Buy 17,877.00 at 9.80p
Day's Volume: 164,092
Last Close: 9.65p
Open: 9.65p
ISIN: GB00B63D3314
Day's Range 9.65p - 9.80p
52wk Range: 7.25p - 17.50p
Market Capitalisation: £100.15m
VWAP: 9.603511p
Shares in Issue: 1.04b

Scancell Holdings (SCLP) Latest Trades

Buy/Sell Volume Trade Prc Trade Type Trade Time
Buy* 17,877 9.80p Suspected BUY Trade
14:00:28 - 30-Oct-25
Sell* 2,000 9.533p Ordinary
13:25:35 - 30-Oct-25
Sell* 30,000 9.55p Ordinary
13:05:34 - 30-Oct-25
Unknown* 5,141 9.65p Ordinary
12:28:57 - 30-Oct-25
Buy* 500 9.80p SI Trade
12:27:29 - 30-Oct-25
Buy* 6,150 9.80p SI Trade
12:27:29 - 30-Oct-25
Buy* 100 9.80p SI Trade
12:27:29 - 30-Oct-25
Buy* 990 9.80p SI Trade
12:27:29 - 30-Oct-25
Buy* 4,167 9.80p SI Trade
12:27:29 - 30-Oct-25
Buy* 5,000 9.80p SI Trade
12:27:29 - 30-Oct-25
See more Scancell Holdings trades

Scancell Holdings (SCLP) Share Price History

Time period:
to
Date Open High Low Close Volume
30th Oct 2025 (Thu) 9.65 9.80 9.65 9.65 164,092
29th Oct 2025 (Wed) 9.65 9.65 9.65 9.65 481,688
28th Oct 2025 (Tue) 9.65 9.65 9.50 9.65 493,270
27th Oct 2025 (Mon) 9.75 10.00 9.65 10.00 4,110,294
24th Oct 2025 (Fri) 9.55 9.75 9.55 9.75 1,102,712
23rd Oct 2025 (Thu) 9.55 9.55 9.55 9.55 62,163
22nd Oct 2025 (Wed) 9.55 9.70 9.55 9.55 348,591
21st Oct 2025 (Tue) 9.55 9.55 9.55 9.55 88,761
20th Oct 2025 (Mon) 9.55 9.55 9.55 9.55 444,527
17th Oct 2025 (Fri) 9.96 9.96 9.10 9.55 326,170
16th Oct 2025 (Thu) 10.20 10.20 9.75 9.75 99,189
15th Oct 2025 (Wed) 9.72 10.00 9.72 9.75 570,999
14th Oct 2025 (Tue) 10.00 9.75 9.50 9.50 674,307
13th Oct 2025 (Mon) 10.00 10.50 10.00 10.00 464,226
10th Oct 2025 (Fri) 9.75 10.00 9.75 9.75 4,747,806
9th Oct 2025 (Thu) 9.75 9.75 9.75 9.75 1,085,286
8th Oct 2025 (Wed) 9.75 9.75 9.50 9.75 970,133
7th Oct 2025 (Tue) 9.75 9.75 9.50 9.75 671,866
6th Oct 2025 (Mon) 9.75 9.75 9.75 9.75 306,544
3rd Oct 2025 (Fri) 9.75 9.75 9.75 9.75 853,499
2nd Oct 2025 (Thu) 9.75 10.00 9.75 9.75 463,849
1st Oct 2025 (Wed) 9.75 9.75 9.75 9.75 354,316
30th Sep 2025 (Tue) 9.75 9.75 9.75 9.75 639,518
See more Scancell Holdings price history

Scancell Holdings (SCLP) Regulatory News

Date Source Headline
3rd Oct 2025 7:00 am RNS Notice of AGM
16th Sep 2025 7:00 am RNS Director Dealing
11th Sep 2025 7:00 am RNS Final Results
4th Sep 2025 7:00 am RNS Notice of Results
8th Aug 2025 12:31 pm RNS Director Dealing
4th Aug 2025 10:23 am RNS Director/PDMR Shareholding
22nd Jul 2025 7:00 am RNS Strong Phase 2 data on iSCIB1+ in Melanoma
16th Jul 2025 7:00 am RNS Share Option Exercise
25th Jun 2025 7:00 am RNS Scancell initiates new arm in SCOPE Phase 2 study
21st May 2025 7:00 am RNS Director Dealing
See more Scancell Holdings regulatory news

Scancell Holdings (SCLP) Share News

UK shareholder meetings calendar - next 7 days

23rd Oct 2025 14:28

Read More

TRADING UPDATES: Gfinity's Yentra partners with ESG Institute

17th Sep 2025 06:55

(Alliance News) - The following is a round-up of trading updates by London-listed companies, issued on Tuesday and not separately reported by Alliance News: Read More

Scancell Holdings notes "tough" macro-environment as loss widens

11th Sep 2025 12:06

(Alliance News) - Scancell Holdings PLC on Thursday said it has made "strong progress" over the last 18 months, but noted impacts from the "tough macroeconomic environment", as it posted a wider full-year loss. Read More

TRADING UPDATES: Scancell reports positive data from melanoma trial

23rd Jul 2025 16:47

(Alliance News) - The following is a round-up of updates and earnings by London-listed companies, issued on Tuesday and not separately reported by Alliance News: Read More

Scancell partners with NHS to fast-track melanoma vaccine trial

14th Apr 2025 14:02

(Alliance News) - Scancell Holdings PLC on Monday said it has partnered with the NHS Cancer Vaccine Launch Pad, to accelerate patient recruitment into the fourth cohort of its phase 2 scope study for a targeted melanoma vaccine. Read More

See more Scancell Holdings news
FTSE 100 Latest
Value9,760.06
Change3.92

Login to your account

Forgot Password?

Not Registered